Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast - A review of 42 primary and secondary cases in Taiwanese patients

Leukemia and Lymphoma

Volumn 50, Issue 6, 2009, Pages 918-924

  Lin, Yu Chin ^a,b   Tsai, Chung Hsin ^c   Wu, Jia Shing ^d   Huang, Chiun Sheng ^a   Kuo, Sung Hsin ^a,e   Lin, Chung Wu ^a   Cheng, Ann Lii ^a,e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

^d KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Breast lymphoma; Extranodal lymphoma; Prognosis; Young age

Indexed keywords

ANTINEOPLASTIC AGENT; RITUXIMAB;

ADULT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; EVENT FREE SURVIVAL; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; LARGE CELL LYMPHOMA; MASTECTOMY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PIMARY BREAST LYMPHOMA; PRIMARY BREAST LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; SECOND CANCER; SECONDARY BREAST LYMPHOMA; SURVIVAL TIME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DRUG THERAPY; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY; SURVIVAL ANALYSIS; TAIWAN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 68449103588     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902777475     Document Type: Article

References (21)

1. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-260.
2. Wiseman C, Liao KT. Primary lymphoma of the breast. Cancer 1972;29:1705-1712.
3. Mambo NC, Burke JS, Butler JJ. Primary malignant lymphomas of the breast. Cancer 1977;39:2033-2040.
4. Lamovec J, Jancar J. Primary malignant lymphoma of the breast. Lymphoma of the mucosa-associated lymphoid tissue. Cancer 1987;60:3033-3041.
5. Ribrag V, Bibeau F, El Weshi A, Frayfer J, Fadel C, Cebotaru C, et al. Primary breast lymphoma: A report of 20 cases. Br J Haematol 2001;115:253-256.
6. Domchek SM, Hecht JL, Fleming MD, Pinkus GS, Canellos GP. Lymphomas of the breast: Primary and secondary involvement. Cancer 2002;94:6-13.
7. Kuper-Hommel MJ, Snijder S, Janssen-Heijnen ML, Vrints LW, Kluin-Nelemans JC, Coebergh JW, et al. Treatment and survival of 38 female breast lymphomas: A population-based study with clinical and pathological reviews. Ann Hematol 2003;82:397-404.
8. Aviles A, Delgado S, Nambo MJ, Neri N, Murillo E, Cletos S. Primary breast lymphoma: Results of a controlled clinical trial. Oncology 2005;69:256-260.
9. Carbone PP, Kaplan HS, Mushoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease classification. Cancer Res 1971;31:1860-1861.
10. Jaffe ES, Harris NL, Stein H, Isaacson PG. Classification of lymphoid neoplasms: The microscope as a tool for disease discovery. Blood 2008;112:4384-4399.
11. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579-586.
12. Wong WW, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience. J Surg Oncol 2002;80:19-25; discussion 26.
13. Lin Y, Guo XM, Shen KW, Wang JL, Jiang GL. Primary breast lymphoma: long-term treatment outcome and prognosis. Leuk Lymphoma 2006;47:2102-2109.
14. Cabras MG, Amichetti M, Nagliati M, Orrù P, Mamusa AM, Angelucci E. Primary non-Hodgkin's lymphoma of the breast: A report of 11 cases. Haematologica 2004;89:1527-1528.
15. Vigliotti ML, Dell'olio M, La Sala A, Di Renzo N. Primary breast lymphoma: Outcome of 7 patients and a review of the literature. Leuk Lymphoma 2005;46:1321-1327.
16. Ganjoo K, Advani R, MariappanMR, McMillan A, Horning S. Non-Hodgkin lymphoma of the breast.Cancer 2007;110:25-30.
17. Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, et al. Primary diffuse large B-cell lymphoma of the breast: Prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol 2008;19:233-241.
18. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987-994.
19. Horning SJ, Weller E, Kim K, Earle JD, O'Connell MJ, Habermann TM, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol 2004;22:3032-3038.
20. Hugh JC, Jackson FI, Hanson J, Poppema S. Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer 1990;66:2602-2611.
21. Jeon HJ, Akagi T, Hoshida Y, Hayashi K, Yoshino T, Tanaka T, et al. Primary non-Hodgkin malignant lymphoma of the breast. An immunohistochemical study of seven patients and literature review of 152 patients with breast lymphoma in Japan. Cancer 1992;70:2451-2459.